Rhoen Klinikum is to get an extra €15m a year for 2017 and annually hereafter until at least 2021 from the state of Hesse for its research and teaching work at Giessen and Marburg, the only privatised University hospital in Germany. CEO Stefan Holzinger's new strategy is to persuade outpatient specialists to move their offices to Rhoen outpatient units to create more referrals in its specialist hospitals and a better patient experience. But 2017 saw an adjusted GAAP EBITDA margin of only 8.1%, low compared to the mid-teens achieved by bigger rivals such as Helios and Sana.